No Detail Found!

Comparison of Various Therapeutic Approaches to Manage Infertility in Polycystic Ovarian Syndrome

Author(s)
Sameena Ahmed Department of Pharmacology, Jinnah Medical and Dental College,Karachi,Pakistan
Samia Perwaiz Khan Department of Pharmacology, Jinnah Medical and Dental College,Karachi,Pakistan
Safia Izhar Department of Radiology, Medicare and General Hospital,Karachi,Pakistan
Sadia Rashid Department of Obstetric Gynaecologist, Medicare and General Hospital,Karachi,Pakistan
Rizwana S. Waraich Department of Biomedical and Biological Sciences, Sohail University,Karachi,Pakistan
Fadieleh A. Sohail Department of Medical Education, Sohail University,Karachi,Pakistan
Abstract
Objective: To compare the e cacies of common therapeutic regimens and their combinations, used in polycystic ovarian syndrome (PCOS) to improve fertility in reproductive-age women. Study Design: A descriptive study. Place and Duration of the Study: Department of Obstetric Gynaecologist, Medicare Cardiac and General Hospital, Karachi, Pakistan, from November 2022 to July 2023. Methodology: Out of 300 patients with the symptoms of menstrual irregularities and infertility, 152 were diagnosed as PCOS patients based on the ultrasound and hormonal assays and selected for study purpose. They were divided according to their therapeutic regimen into four treatment groups, treated by di erent therapeutic agents. Group A received metformin 500 mg/day (n = 38); Group B received metformin + myo-inositol 1g (n = 49); Group C received metformin + letrozole 2.5 mg (n = 36), and Group D received metformin + letrozole + myo-inositol (n = 29), orally for three months. All continuous variables, such as body mass index (BMI), FSH, LH, FT4, and FSI were analysed by applying t-test to all therapeutic groups, keeping p d0.05 as the level of signi cance. Results: HCG-positive was found as 86% (n = 33) in Group A, 63% (n = 31) in Group B, 52% (n = 19) in Group C, and 27% (n = 08) in Group D. There were statistically signi cant (p <0.001) changes in BMI, FSH, LH, FT4, and FSI as well. Metformin alone and metformin plus myo-inositol came out to be more e ective than other regimens. Conclusion: Metformin alone and myo-inositol plus metformin are e ective therapeutic options in PCOS-induced infertility problems.
Publication Details
Page(s) 654-658
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 34, Issue: 6, Year: 2024

Request the full text from PASTIC

Keywords
Infertility, Polycystic ovarian syndrome, Metformin, Menstrual irregularities, Letrozole, Infertility, Myo-inositol
0

Citations

0

Downloads

117

Views